[1]杨惠玲.细胞增殖和凋亡异常与疾病//金惠铭.病理生理学.北京：人民卫生出版社，2013：141-151.

[2]龚建平.细胞周期与肿瘤发生、发展//曾盖新.肿瘤学.北京：人民卫生出版社，2014：122-126.

[3]Zhou Y，Shen JK，Hornicek FJ，et al.The Emerging Roles and Therapeutic Potential of Cyclin-Dependent Kinase 11（Cdk11）in Human Cancer.Oncotarget，2016，7（26）：40846-40859.

[4]Liang K，Gao X，Gilmore JM，et al.Characterization of Human Cyclin-Dependent Kinase 12（Cdk12）and Cdk13 Complexes in C-Terminal Domain Phosphorylation，Gene Transcription，and Rna Processing.Mol Cell Biol，2015，35（6）：928-938.

[5]Chila R，Guffanti F，Damia G.Role and Therapeutic Potential of Cdk12 in Human Cancers.Cancer Treat Rev，2016，50：83-88.

[6]Even Y，Escande M.，Fayet C，et al.Cdk13，a Kinase Involved in Pre-Mrna Splicing，is a Component of the Perinucleolar Compartment.PLoS One，2016，11 （2）：e149184.

[7]Stivala LA，Riva F，Cazzalini O，et al.P21（Waf1/Cip1）-Null Human Fibroblasts are Deficient in Nucleotide Excision Repair Downstream the Recruitment of Pcna to Dna Repair Sites.Oncogene，2001，20（5）：563-570.

[8]Lecanda J，Ganapathy V，D’Aquino-Ardalan C，et al.Tgfbeta Prevents Proteasomal Degradation of the Cyclin-Dependent Kinase Inhibitor P27Kip1 for Cell Cycle Arrest.Cell Cycle，2009，8（5）：742-756.

[9]Tu Y，Chen C，Pan J，et al.The Ubiquitin Proteasome Pathway（Upp）in the Regulation of Cell Cycle Control and Dna Damage Repair and its Implication in Tumorigenesis.International Journal of Clinical and Experimental Pathology，2012，5（8）：726.

[10]Cui H，Zhao C，Gong P，et al.Dna Methyltransferase 3a Promotes Cell Proliferation by Silencing Cdk Inhibitor P18Ink4C in Gastric Carcinogenesis.Sci Rep，2015，5：13781.

[11]Nakayama KI，Nakayama K.Ubiquitin Ligases：Cell-Cycle Control and Cancer.Nat Rev Cancer，2006，6（5）：369-381.

[12]He D，Zeng Q，Ren G，et al.Protocadherin8 is a Functional Tumor Suppressor Frequently Inactivated by Promoter Methylation in Nasopharyngeal Carcinoma.European journal of cancer prevention：the official journal of the European Cancer Prevention Organisation（ECP），2012，21（6）：569.

[13]张颖.Cyclind1、Cdk4及P16在糖尿病早期肾脏细胞的表达.河北医科大学，硕士，2003：53.

[14]Taniguchi Y，Pippin JW，Hagmann H，et al Both Cyclin I and P35 are Required for Maximal Survival Benefit of Cyclin-Dependent Kinase 5 in Kidney Podocytes.Am J Physiol Renal Physiol，2012，302（9）：F1161-F1171.

[15]Parrales A，Iwakuma T.Targeting Oncogenic Mutant P53 for Cancer Therapy.Front Oncol，2015，5：288.

[16]Zhang R，Wang H，Agrawal S.Novel Antisense Anti-Mdm2 Mixed-Backbone Oligonucleotides：Proof of Principle，in Vitro and in Vivo Activities，and Mechanisms.Curr Cancer Drug Targets，2005，5（1）：43-49.

[17]刘斌，高英茂.人体胚胎学.北京：人民卫生出版社，1996.

[18]杨洋，文继红.卵巢恶性畸胎瘤研究进展.吉林医学，2010，4：543-545.

[19]Greene Nd CA.Neural-Tube Defects.Annu Rev Neurosci，2014，341（37）：221-242.

[20]Srivastava D.Making Or Breaking the Heart：From Lineage Determination to Morphogenesis.Cell，2006，6（126）：1037-1048.

[21]吴德沛.白血病//葛均波，徐永健.内科学.北京：人民卫生出版社，2013：578-592.

[22]陈国强.细胞分化和肿瘤//肿瘤学.北京：人民卫生出版社，2014：129-135.

[23]Chen Z，Breitman TR.Effects of Prostaglandin E2 and All-Trans Retinoic Acid Combination On Induced Differentiation of Human Acute Promyelocytic Leukemia Nb4 Cells.Chin Med J（Engl），1997，110（10）：783-788.

[24]Soignet SL，Frankel SR，Douer D，et al.United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia.J Clin Oncol，2001，19（18）：3852-3860.